Bar-Ilan University Makes Breakthrough in Alzheimer’s Treatment

Researchers from Bar-Ilan University have developed a new approach to combating Alzheimer’s disease.

This innovative technique utilizes nanotechnology and ultra-low-energy X-rays to prevent the aggregation of amyloid beta (A-beta) proteins, which are central to the disease’s progression. The method has shown potential in preclinical models for selectively targeting and irradiating the affected regions of the brain.

The unique advantage of this approach lies in its potential to selectively target and irradiate the affected regions of the brain, minimizing the risk of side effects associated with traditional antibody-based therapies.

With a patent secured for their novel treatment and early success in animal trials, the research team at Bar-Ilan is optimistic it could significantly slow Alzheimer’s in its early stages.

“This approach has shown promising results in neuronal cell cultures and animal models, offering new possibilities for early intervention in Alzheimer’s disease,” says Bar-Ilan professor Shai Rahimipour.

“Our ultimate goal is to develop a safe and effective treatment for individuals in the early stages of Alzheimer’s, with a focus on those at high risk, such as those with familial Alzheimer’s,” he said.